Sebaloxavir Marboxil

玛硒洛沙韦

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameSebaloxavir Marboxil
Drug Alias Name玛赛洛沙韦seloxavir marboxil济可舒ZX-7101AZX7101A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase acidic protein inhibitors
TargetsPolymerase acidic protein
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanRespiratory Tract Infections +[4] 
Global Approved IndicationsInfluenza A virus infectionsInfluenza B virus infection
Approved Indications in ChinaInfluenza A virus infectionsInfluenza B virus infection
Original Approved Country/TerritoryMainland China
Original Approved Date2025/07/15
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNanjing Zenshine Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Zenshine Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanRespiratory Tract Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A